Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

1.

Novel effects of hormonal contraceptive use on the plasma proteome.

Josse AR, Garcia-Bailo B, Fischer K, El-Sohemy A.

PLoS One. 2012;7(9):e45162. doi: 10.1371/journal.pone.0045162. Epub 2012 Sep 12.

PMID:
22984625
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Dietary patterns and ethnicity are associated with distinct plasma proteomic groups.

García-Bailo B, Brenner DR, Nielsen D, Lee HJ, Domanski D, Kuzyk M, Borchers CH, Badawi A, Karmali MA, El-Sohemy A.

Am J Clin Nutr. 2012 Feb;95(2):352-61. doi: 10.3945/ajcn.111.022657. Epub 2011 Dec 28.

PMID:
22205312
[PubMed - indexed for MEDLINE]
Free Article
3.

Plasma 25-hydroxyvitamin D, hormonal contraceptive use, and the plasma proteome in Caucasian, East Asian, and South Asian young adults.

García-Bailo B, Jamnik J, Da Costa LA, Borchers CH, Badawi A, El-Sohemy A.

J Proteome Res. 2013 Apr 5;12(4):1797-807. doi: 10.1021/pr4001042. Epub 2013 Mar 6.

PMID:
23427916
[PubMed - indexed for MEDLINE]
4.

Plasma 25-hydroxyvitamin D, hormonal contraceptive use, and cardiometabolic disease risk in an ethnically diverse population of young adults.

García-Bailo B, Karmali M, Badawi A, El-Sohemy A.

J Am Coll Nutr. 2013;32(5):296-306. doi: 10.1080/07315724.2013.826112.

PMID:
24219372
[PubMed - indexed for MEDLINE]
5.

Positive association between 25-hydroxyvitamin D and C-reactive protein is confounded by hormonal contraceptive use.

García-Bailo B, Josse AR, Jamnik J, Badawi A, El-Sohemy A.

J Womens Health (Larchmt). 2013 May;22(5):417-25. doi: 10.1089/jwh.2012.4046.

PMID:
23659482
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Use of combined oral contraceptives alters metabolic determinants and genetic regulation of C-reactive protein. The Cardiovascular Risk in Young Finns Study.

Haarala A, Eklund C, Pessi T, Lehtimäki T, Huupponen R, Jula A, Viikari J, Raitakari O, Hurme M.

Scand J Clin Lab Invest. 2009;69(2):168-74. doi: 10.1080/00365510802449642.

PMID:
18937150
[PubMed - indexed for MEDLINE]
7.

Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease.

Godsland IF, Crook D, Devenport M, Wynn V.

Contraception. 1995 Sep;52(3):143-9.

PMID:
7587185
[PubMed - indexed for MEDLINE]
8.

Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.

Quehenberger P, Loner U, Kapiotis S, Handler S, Schneider B, Huber J, Speiser W.

Thromb Haemost. 1996 Nov;76(5):729-34.

PMID:
8950781
[PubMed - indexed for MEDLINE]
9.

Glutathione S-transferase (GST) M1, but not GSTT1, genotype influences plasma proteomic profiles in Caucasian and East Asian young adults.

Fischer K, Da Costa LA, García-Bailo B, Borchers CH, El-Sohemy A.

J Proteome Res. 2012 Oct 5;11(10):5022-33. doi: 10.1021/pr3005887. Epub 2012 Sep 18.

PMID:
22946785
[PubMed - indexed for MEDLINE]
10.

A study of the interactive effects of oral contraceptive use and dietary fat intake on blood pressure, cardiovascular reactivity and glucose tolerance in normotensive women.

Straznicky NE, Barrington VE, Branley P, Louis WJ.

J Hypertens. 1998 Mar;16(3):357-68.

PMID:
9557929
[PubMed - indexed for MEDLINE]
11.

Effects of third-generation oral contraceptives on high-sensitivity C-reactive protein and homocysteine in young women.

Cauci S, Di Santolo M, Culhane JF, Stel G, Gonano F, Guaschino S.

Obstet Gynecol. 2008 Apr;111(4):857-64. doi: 10.1097/AOG.0b013e31816a2476.

PMID:
18378744
[PubMed - indexed for MEDLINE]
12.

Association between the plasma proteome and serum ascorbic acid concentrations in humans.

Da Costa LA, García-Bailo B, Borchers CH, Badawi A, El-Sohemy A.

J Nutr Biochem. 2013 May;24(5):842-7. doi: 10.1016/j.jnutbio.2012.05.002. Epub 2012 Jul 25.

PMID:
22841398
[PubMed - indexed for MEDLINE]
13.

A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins.

Crook D, Godsland IF, Worthington M, Felton CV, Proudler AJ, Stevenson JC.

Am J Obstet Gynecol. 1993 Nov;169(5):1183-9.

PMID:
8238183
[PubMed - indexed for MEDLINE]
14.

Sex hormone-binding globulin as a marker for the thrombotic risk of hormonal contraceptives.

Raps M, Helmerhorst F, Fleischer K, Thomassen S, Rosendaal F, Rosing J, Ballieux B, VAN Vliet H.

J Thromb Haemost. 2012 Jun;10(6):992-7. doi: 10.1111/j.1538-7836.2012.04720.x.

PMID:
22469296
[PubMed - indexed for MEDLINE]
16.

[Significance of hormonal contraceptives for coronary heart disease].

Gohlke-Bärwolf C.

Herz. 1987 Aug;12(4):263-75. Review. German.

PMID:
3308662
[PubMed - indexed for MEDLINE]
17.

Effects of oral contraceptives on carbohydrate and lipid metabolisms in a healthy population: the Telecom study.

Simon D, Senan C, Garnier P, Saint-Paul M, Garat E, Thibult N, Papoz L.

Am J Obstet Gynecol. 1990 Jul;163(1 Pt 2):382-7.

PMID:
2196809
[PubMed - indexed for MEDLINE]
19.

Hormonal versus non-hormonal contraceptives in women with diabetes mellitus type 1 and 2.

Visser J, Snel M, Van Vliet HA.

Cochrane Database Syst Rev. 2006 Oct 18;(4):CD003990. Review. Update in: Cochrane Database Syst Rev. 2013;3:CD003990.

PMID:
17054193
[PubMed - indexed for MEDLINE]
20.

A proteomic approach identifies early pregnancy biomarkers for preeclampsia: novel linkages between a predisposition to preeclampsia and cardiovascular disease.

Blumenstein M, McMaster MT, Black MA, Wu S, Prakash R, Cooney J, McCowan LM, Cooper GJ, North RA.

Proteomics. 2009 Jun;9(11):2929-45. doi: 10.1002/pmic.200800625.

PMID:
19444803
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk